164 related articles for article (PubMed ID: 27760332)
1. PKA Has the Gall to Oppose NLRP3.
Groß CJ; Groß O
Immunity; 2016 Oct; 45(4):707-709. PubMed ID: 27760332
[TBL] [Abstract][Full Text] [Related]
2. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.
Guo C; Xie S; Chi Z; Zhang J; Liu Y; Zhang L; Zheng M; Zhang X; Xia D; Ke Y; Lu L; Wang D
Immunity; 2016 Oct; 45(4):802-816. PubMed ID: 27692610
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
4. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
Tang T; Gong T; Jiang W; Zhou R
Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.
Mortimer L; Moreau F; MacDonald JA; Chadee K
Nat Immunol; 2016 Oct; 17(10):1176-86. PubMed ID: 27548431
[TBL] [Abstract][Full Text] [Related]
6. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
Shirasuna K; Karasawa T; Takahashi M
J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
[TBL] [Abstract][Full Text] [Related]
7. Role of NLRP3 Inflammasomes in Neuroinflammation Diseases.
Lin S; Mei X
Eur Neurol; 2020; 83(6):576-580. PubMed ID: 33202405
[TBL] [Abstract][Full Text] [Related]
8. AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging.
Cordero MD; Williams MR; Ryffel B
Trends Endocrinol Metab; 2018 Jan; 29(1):8-17. PubMed ID: 29150317
[TBL] [Abstract][Full Text] [Related]
9. If a butterfly flaps its wings in the Amazon, do we form an Inflammasome?
Mansell A
Mol Immunol; 2017 Jun; 86():1-2. PubMed ID: 28566128
[No Abstract] [Full Text] [Related]
10. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
11. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
12. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphorylation on the NLRP3 inflammasome.
Sandall CF; MacDonald JA
Arch Biochem Biophys; 2019 Jul; 670():43-57. PubMed ID: 30844378
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Pharmacology of the NLRP3 Inflammasome.
Abbate A; Booz GW
J Cardiovasc Pharmacol; 2019 Sep; 74(3):173-174. PubMed ID: 31498192
[No Abstract] [Full Text] [Related]
16. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome: a promising target in ischemic stroke.
Gao L; Dong Q; Song Z; Shen F; Shi J; Li Y
Inflamm Res; 2017 Jan; 66(1):17-24. PubMed ID: 27576327
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Front Immunol; 2020; 11():618231. PubMed ID: 33603747
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide regulates glycolysis-dependent NLRP3 inflammasome activation in macrophages.
Lee DW; Shin HY; Jeong JH; Han J; Ryu S; Nakahira K; Moon JS
Biochem Biophys Res Commun; 2017 Nov; 493(2):957-963. PubMed ID: 28942141
[TBL] [Abstract][Full Text] [Related]
20. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
